231 related articles for article (PubMed ID: 15778700)
1. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia.
Crocker IP; Kenny LC; Thornton WA; Szabo C; Baker PN
Br J Pharmacol; 2005 Mar; 144(6):772-80. PubMed ID: 15778700
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation.
Pacher P; Mabley JG; Soriano FG; Liaudet L; Komjáti K; Szabó C
Br J Pharmacol; 2002 Mar; 135(6):1347-50. PubMed ID: 11906946
[TBL] [Abstract][Full Text] [Related]
3. Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.
Walsh SK; English FA; Crocker IP; Johns EJ; Kenny LC
Br J Pharmacol; 2012 Aug; 166(7):2109-16. PubMed ID: 22339234
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.
Tasatargil A; Tekcan M; Celik-Ozenci C; Ece Gungor N; Dalkiran B
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):127-37. PubMed ID: 19713411
[TBL] [Abstract][Full Text] [Related]
6. Activation of poly [ADP-Ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesication.
Hinshaw DB; Lodhi IJ; Hurley LL; Atkins KB; Dabrowska MI
Toxicol Appl Pharmacol; 1999 Apr; 156(1):17-29. PubMed ID: 10101095
[TBL] [Abstract][Full Text] [Related]
7. Effects of 7-ketocholesterol on the activity of endothelial poly(ADP-ribose) polymerase and on endothelium-dependent relaxant function.
Kiss L; Chen M; Gero D; Módis K; Lacza Z; Szabó C
Int J Mol Med; 2006 Dec; 18(6):1113-7. PubMed ID: 17089016
[TBL] [Abstract][Full Text] [Related]
8. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging.
Pacher P; Mabley JG; Soriano FG; Liaudet L; Szabó C
Int J Mol Med; 2002 Jun; 9(6):659-64. PubMed ID: 12011985
[TBL] [Abstract][Full Text] [Related]
9. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.
Mathews MT; Berk BC
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):711-7. PubMed ID: 18239155
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta.
Tasatargil A; Dalaklioglu S; Sadan G
Pharmacology; 2004 Oct; 72(2):99-105. PubMed ID: 15331915
[TBL] [Abstract][Full Text] [Related]
12. Altered endothelial function in isolated human myometrial vessels induced by plasma from women with pre-eclampsia is not reproducible in isolated mouse vessels.
Myers J; Irvine R; Gillham J; Macleod M; Mires G; Taggart M; Baker P
Clin Sci (Lond); 2005 May; 108(5):457-62. PubMed ID: 15673282
[TBL] [Abstract][Full Text] [Related]
13. Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells.
Mahrouf-Yorgov M; Marie N; Borderie D; Djelidi R; Bonnefont-Rousselot D; Legrand A; Beaudeux JL; Peynet J
Metabolism; 2009 Apr; 58(4):525-33. PubMed ID: 19303974
[TBL] [Abstract][Full Text] [Related]
14. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.
Garcia Soriano F ; Virág L; Jagtap P; Szabó E; Mabley JG; Liaudet L; Marton A; Hoyt DG; Murthy KG; Salzman AL; Southan GJ; Szabó C
Nat Med; 2001 Jan; 7(1):108-13. PubMed ID: 11135624
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
16. Administration of the PARP inhibitor Pj34 ameliorates the impaired vascular function associated with eNOS(-/-) mice.
English FA; McCarthy FP; Andersson IJ; Stanley JL; Davidge ST; Baker PN; Walsh SK; Kenny LC
Reprod Sci; 2012 Aug; 19(8):806-13. PubMed ID: 22421449
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.
Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M
J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042
[TBL] [Abstract][Full Text] [Related]
18. The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia.
Abdallah Y; Gligorievski D; Kasseckert SA; Dieterich L; Schäfer M; Kuhlmann CR; Noll T; Sauer H; Piper HM; Schäfer C
Cardiovasc Res; 2007 Feb; 73(3):568-74. PubMed ID: 17196568
[TBL] [Abstract][Full Text] [Related]
19. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.
Szabó C; Pacher P; Zsengellér Z; Vaslin A; Komjáti K; Benkö R; Chen M; Mabley JG; Kollai M
Mol Med; 2004; 10(1-6):28-35. PubMed ID: 15502880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
